Aclaris Therapeutics, Inc. (ACRS) Shareholders’ equity 2017–2025
Aclaris Therapeutics, Inc. (ACRS) shareholders’ equity at each fiscal year-end, per SEC filings.
$103.1MFY2025 · since FY2017: $225.3M → $103.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $103.1M | -33.7% |
| FY2024 | $155.6M | -1.0% |
| FY2023 | $157.2M | -20.5% |
| FY2022 | $197.6M | +0.1% |
| FY2021 | $197.3M | +424.1% |
| FY2020 | $37.6M | -46.1% |
| FY2019 | $69.9M | -67.5% |
| FY2018 | $215.1M | -4.5% |
| FY2017 | $225.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice